Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 27;108(1):e9-e11.
doi: 10.1093/bjs/znaa021.

Berberine reduces circulating inflammatory mediators in patients with severe COVID-19

B Y Zhang  1 , M Chen  1 , X C Chen  1 , K Cao  1 , Y You  1 , Y J Qian  1 , W K Yu  1
Affiliations

Berberine reduces circulating inflammatory mediators in patients with severe COVID-19

B Y Zhang et al. Br J Surg. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Blood concentrations of inflammatory mediators in patients with severe COVID-19 in the two treatment groups and the subgroups with diarrhoea a Interleukin (IL) 6; b IL-6 in subgroups with diarrhoea; c tumour necrosis factor (TNF) α; d TNF-α in subgroups with diarrhoea; e C-reactive protein (CRP); f CRP in subgroups with diarrhoea; g procalcitonin; h procalcitonin in subgroups with diarrhoea; i white blood cell count (WBC); j WBC in subgroups with diarrhoea. Values are median (i.q.r.). There were 18 patients in the berberine group and 17 in the control group, with six and five patients in the respective subgroups with diarrhoea. *P < 0.050, berberine versus control group (generalized linear mixed model).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li X Wang L Yan S, Yang F, Xiang L, Zhu J et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis 2020;94:128–132. - PMC - PubMed
    1. Zhou F Yu T Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062. - PMC - PubMed
    1. Hou Q Zhu S Zhang C, Huang Y, Guo Y, Li P et al. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice. Biomed Pharmacother 2019;118:109206. - PubMed
    1. National Health Commission. Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 7) China, 2020. http://www.nhc.gov.cn/wjw/zcjd/list_6.shtml (accessed 24 July 2020)
    1. Carnevale S, Beretta P, Morbini P. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol 2020; DOI:10.1002/jmv.26119 [Epub ahead of print] - PMC - PubMed

MeSH terms